Journal of Traditional Chinese Medicine, with the ISSN 0255-2922 and E-ISSN 1577-7014, is a distinguished publication dedicated to exploring the rich heritage and contemporary applications of Chinese medicinal practices. Published by JOURNAL TRADITIONAL CHINESE MED in China, this journal contributes significantly to the field of Complementary and Alternative Medicine, holding a respectable Q2 ranking in this category according to the 2023 metrics, and a Q3 ranking in miscellaneous medicine. With its coverage spanning from 1996 to 2024, the journal aims to advance scholarly research and foster an understanding of traditional Chinese healing methodologies, blending ancient wisdom with modern healthcare paradigms. While currently not classified as Open Access, it provides critical insights and detailed analyses that are invaluable for researchers, healthcare professionals, and students interested in the intersection of tradition and innovation in medical practices.

Phytotherapy Research, a distinguished journal published by Wiley, stands at the forefront of the pharmacological literature, delivering essential insights into the therapeutic potential of plant-based interventions. With its ISSN 0951-418X and E-ISSN 1099-1573, the journal has firmly established itself since its inception in 1987, now converging into its 2024 volume. Notably positioned in the Q1 category of Pharmacology and ranked #22 out of 313 journals in the field, it boasts a remarkable 93rd percentile rating according to Scopus. While the journal adheres to subscription-based access, it remains a crucial repository of high-quality research findings that support the understanding and advancement of herbal medicines and phytotherapeutics. This journal serves as an invaluable resource for researchers, healthcare professionals, and students alike, fostering a deeper exploration of the synergistic relationship between nature and medicine and promoting evidence-based practices in the field.

Medical Acupuncture is a dedicated peer-reviewed journal that focuses on the intersection of integrative health practices and traditional medicine, particularly emphasizing acupuncture as an evidence-based therapeutic modality. Published by MARY ANN LIEBERT, INC, this journal serves as a pivotal resource for researchers, clinicians, and students in the field of Complementary and Alternative Medicine. With an ISSN of 1933-6586, it has established itself within the academic community, boasting a 2023 Scopus rank of #61 out of 105 in its category, placing it in the 42nd percentile. Although not an open-access journal, it offers a comprehensive platform for exploring the latest developments, clinical applications, and research findings related to acupuncture and its effectiveness in patient care. As it converges years of knowledge from 2008 to 2024, Medical Acupuncture continues to enhance understanding of the therapeutic potential of acupuncture and foster professional discourse in this vital area of health and wellness.

MEDICINE, published by Lippincott Williams & Wilkins, is an esteemed open access journal in the field of general medicine, holding a significant position with a Scopus rank of #190 out of 636 in its category (2023), placing it in the 70th percentile. Since its inception in 1922, MEDICINE has been a vital platform for researchers, professionals, and students to disseminate groundbreaking findings and advancements in the medical field. With the transition to open access in 2014, the journal ensures that valuable research is readily available to a global audience, fostering collaboration and innovation across diverse medical disciplines. Its current impact factor and influence in the miscellaneous medicine category (Q3) reflect its commitment to supporting rigorous peer-review processes and promoting scholarly excellence. Located in Philadelphia, PA, the journal covers a wide range of topics, making it a crucial resource for those dedicated to the betterment of healthcare and medical education.

BMC Complementary Medicine and Therapies is a leading open-access journal published by BMC in the United Kingdom, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in the category of Complementary and Alternative Medicine as of 2023, and ranking #18 out of 105 in the Scopus database, placing it in the 83rd percentile among its peers. The journal’s mission is to disseminate high-quality research that contributes to a better understanding of the efficacy, safety, and practical application of complementary therapies. With its open-access model, BMC Complementary Medicine and Therapies ensures that valuable research findings are freely accessible to researchers, healthcare practitioners, and students alike, fostering collaboration and innovation across disciplines. The journal publishes original research, reviews, and clinical studies, providing a comprehensive platform for the exploration of diverse therapeutic modalities.

ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH, published by COGNIZANT COMMUNICATION CORP, is a pivotal journal that delves into the intricate relationship between acupuncture, electro-therapeutics, and their applications in the fields of anesthesiology, pain medicine, and complementary therapies. With an ISSN of 0360-1293 and an E-ISSN of 2167-9010, this esteemed journal has been serving the academic community since 1976 and will continue to publish groundbreaking research until 2024. Despite its current positioning within the Q4 quartiles for both anesthesiology and complementary medicine, ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH remains a valuable platform for disseminating innovative studies that push the boundaries of traditional pain management and neuroscience. Researchers, students, and professionals interested in exploring contemporary therapeutic modalities will find this journal an indispensable resource for understanding the efficacy and applications of acupuncture and electro-therapeutics. With a focus on advancing knowledge in these domains, the journal aims to foster a deeper understanding of integrative approaches to health and wellness.

Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.

World Journal of Traditional Chinese Medicine, published by Wolters Kluwer Medknow Publications, is a prestigious open-access journal dedicated to advancing the field of Complementary and Alternative Medicine. Since its inception in 2014, this journal has provided a vital platform for researchers, practitioners, and students to share critical insights, original research, and reviews pertaining to Traditional Chinese Medicine (TCM). With an impressive impact factor, placing it in the Q1 category of the 2023 Scopus rankings for Complementary and Alternative Medicine, and ranked #23 out of 105 journals in this discipline, the World Journal of Traditional Chinese Medicine stands as a cornerstone for the promotion and acknowledgment of TCM in the global academic landscape. Operating from India, it fosters a collaborative community of scholars aiming to explore and expand the boundaries of knowledge in holistic health practices. The journal’s open-access model ensures that important research findings are readily accessible, promoting greater dissemination and engagement with traditional medical practices worldwide.

Drug Discoveries and Therapeutics is a highly regarded journal devoted to the advancement of knowledge in the field of medicine and pharmacology. Published by the International Research & Cooperation Association for Biological & Socio-Sciences Advancement in Tokyo, Japan, this journal serves as a vital resource for researchers, practitioners, and students interested in the latest developments in drug discovery and therapeutic strategies. With a Scopus ranking of #192 out of 826 in the General Medicine category, and positioning itself in the 76th percentile, it demonstrates a significant impact within the scientific community. The journal publishes original research articles, reviews, and innovative studies that address the complexities of drug development, therapeutic efficacy, and clinical applications. Researchers and clinicians can access valuable insights to enhance their practices and inform further studies as it continues to disseminate crucial findings essential for the advancement of medical science.

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.